TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Austar Lifesciences Ltd. ( (HK:6118) ) just unveiled an announcement.
Austar Lifesciences Limited has announced that its board of directors will hold a meeting on March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The board will also consider recommending a final dividend payment, which could impact the company’s financial strategy and shareholder returns.
More about Austar Lifesciences Ltd.
Austar Lifesciences Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It is listed on the Hong Kong Stock Exchange and focuses on providing products and services related to life sciences.
YTD Price Performance: 50.88%
Average Trading Volume: 152,160
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$425.4M
Learn more about 6118 stock on TipRanks’ Stock Analysis page.